Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 Cells

Tulin Ozkan1, Yalda Hekmatshoar1, Tugba Ertan-Bolelli2

  • 1Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey.

Abstract

Insights

The novel compound XT5 shows significant anticancer effects and enhances imatinib efficacy in Chronic Myeloid Leukemia (CML) cells. This combination therapy offers a promising strategy to overcome imatinib resistance in CML patients.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Imatinib is a first-line treatment for Chronic Myeloid Leukemia (CML).
  • Therapy failure and resistance to imatinib are significant clinical challenges.
  • Novel drug combinations are being explored to improve CML treatment outcomes.

Purpose of the Study:

  • To investigate the antileukemic and apoptotic effects of XT5 and XT2B, alone and in combination with imatinib.
  • To evaluate these effects in both imatinib-sensitive (K562S) and imatinib-resistant (K562R) CML cell lines.
  • To explore the potential of XT5 as a new anticancer agent and combination therapy for CML.

Main Methods:

  • In vitro cytotoxicity assessed using MTT assay.
  • Apoptotic effects evaluated via Annexin V flow cytometry, caspase activation assays, and RT-PCR.
  • Molecular docking studies performed using AutoDock Vina to analyze drug-target interactions.

Main Results:

  • XT5 demonstrated significant antiproliferative and pro-apoptotic effects on CML cell lines.
  • Combination of XT5 with imatinib enhanced cytotoxicity and apoptosis induction (Annexin V binding, caspase 3/7 activation).
  • XT5 treatment increased the expression of pro-apoptotic genes (BAX, BAD, BIM) and showed favorable molecular interactions with the BCR-ABL kinase receptor.

Conclusions:

  • XT5 is a potential candidate for a new anticancer drug.
  • Combining XT5 with imatinib represents a viable strategy to overcome imatinib resistance in CML.
  • Further research into XT5 and its combinations is warranted for CML treatment.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
Rate-Determining Steps03:08

Rate-Determining Steps

Relating Reaction Mechanisms
In a multistep reaction mechanism, one of the elementary steps progresses significantly slower than the others. This slowest step is called the rate-limiting step (or rate-determining step). A reaction cannot proceed faster than its slowest step, and hence, the rate-determining step limits the overall reaction rate.
The concept of rate-determining step can be understood from the analogy of a 4-lane freeway with a short-stretch of traffic-bottleneck caused due to...
37.6K
Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy03:07

Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy

The kinetic molecular theory qualitatively explains the behaviors described by the various gas laws. The postulates of this theory may be applied in a more quantitative fashion to derive these individual laws.
30.0K
Real Gases: Effects of Intermolecular Forces and Molecular Volume Deriving Van der Waals Equation04:01

Real Gases: Effects of Intermolecular Forces and Molecular Volume Deriving Van der Waals Equation

Thus far, the ideal gas law, PV = nRT, has been applied to a variety of different types of problems, ranging from reaction stoichiometry and empirical and molecular formula problems to determining the density and molar mass of a gas. However, the behavior of a gas is often non-ideal, meaning that the observed relationships between its pressure, volume, and temperature are not accurately described by the gas laws.
39.3K